15% OFF MT-II – 10mg/vial (Research Use Only)
Melanotan II, a synthetic melanocortin receptor agonist (MC1R–MC4R) studied in melanocortin receptor pharmacology. Supplied for laboratory research and identification purposes only.
Availability: In stock
3–4 vials — 5% off · 5–9 vials — 10% off · 10+ vials — 15% off
Applied automatically in the cart. Combines with a discount code up to 20% off in total, and stacks on top of the subscription discount.
Research Disclaimer: All products currently listed on this site are for research purposes only.
Overview
Melanotan II (MT-II) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) with broad, non-selective melanocortin receptor agonist activity across MC1R through MC5R subtypes. Originally developed at the University of Arizona as part of a research program to identify sunless tanning agents, Melanotan II’s research profile has expanded across melanocortin receptor pharmacology, central nervous system behavioral research, metabolic biology, and cardiovascular studies. Its structural parent, PT-141 (Bremelanotide), was derived from MT-II with modifications to improve tolerability, providing a natural comparative pharmacology pairing for melanocortin receptor research.
What It Is
Melanotan II is a cyclic lactam heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂, molecular formula C₅₀H₆₉N₁₅O₉, MW approximately 1,024.18 Da, CAS number 121062-08-6. Its broad melanocortin receptor activation profile (MC1R-MC5R) distinguishes it from PT-141 (which is more selective for MC3R/MC4R) and from natural α-MSH. The cyclization and Nle substitution provide metabolic stability exceeding that of linear α-MSH analogues.
Key Research Applications
- Broad-spectrum melanocortin receptor (MC1R–MC5R) pharmacology and selectivity research
- Melanocyte pigmentation, MC1R activation, and melanogenesis biology studies
- MC3R and MC4R CNS pathway research — appetite, arousal, and reward circuit studies
- Comparative melanocortin receptor agonist pharmacology vs. PT-141 (bremelanotide) and α-MSH
- Cardiovascular research — MC3R/MC4R mediated blood pressure and cardiac effects
- Anti-inflammatory melanocortin pathway studies via peripheral MC receptor activation
- Cyclic α-MSH analogue structure-activity relationship (SAR) research
- Peripheral MC4R/MC5R tissue receptor biology studies in smooth muscle preparations
Technical Specifications
| Structure | Cyclic lactam heptapeptide |
| Molecular Formula | C₅₀H₆₉N₁₅O₉ |
| Molecular Weight | ~1,024.18 Da |
| CAS Number | 121062-08-6 |
| Receptor Profile | Broad MC1R–MC5R agonist |
| Purity | ≥98% (supplier specification) |
| Form | Lyophilized powder |
| Vial Size | 10mg |
For laboratory research use only. Not intended for human or veterinary use, medical diagnosis, treatment, or prevention of any disease or condition. This product has not been evaluated by the FDA or any regulatory agency. Must be handled by qualified research personnel in a compliant laboratory setting.
Not sure which compounds fit your research? Browse the Research Hub →
- Processing: Orders ship within 1–2 business days
- Domestic delivery: 3–5 business days via USPS Priority / UPS Ground
- Free shipping on orders over $100
- Temperature handling: Cold-chain packaging available on request for lyophilized peptides
- Tracking: Emailed automatically at time of dispatch
- Store lyophilized (dry) peptides at −4 °F for long-term stability
- Protect from light and moisture at all times
- Do not freeze
- Where the Storage row in the product specification above differs, follow the specification
Pairs Well With
Related research products
Reviews
There are no reviews yet.